Literature DB >> 28090218

Role of T1 Mapping in Inherited Cardiomyopathies.

Peter P Swoboda1, Adam K McDiarmid2, Stephen P Page3, John P Greenwood1, Sven Plein1.   

Abstract

T1 mapping by cardiovascular magnetic resonance is a rapidly evolving method for the quantitative assessment of tissue characteristics in cardiac disease. The myocardial T1 time can be measured without contrast (native T1) or following the administration of intravenous gadolinium-based contrast agent (post-contrast T1). By combining both of these measures, the myocardial extracellular volume fraction can be approximated. This value has been validated histologically in various inherited cardiomyopathies. Due to overlapping phenotypes, the diagnosis of inherited cardiomyopathy can at times be challenging. In this article we discuss when T1 mapping may be a useful tool in the differential diagnosis of cardiomyopathy. We also present evidence of when T1 mapping provides incremental risk stratification over other biomarkers.

Entities:  

Keywords:  T1 mapping; cardiomyopathy; cardiovascular magnetic resonance; extracellular volume

Year:  2016        PMID： 28090218      PMCID： PMC5228763          DOI： 10.15420/ecr/2016:28:2

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN： 1758-3756


  56 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Authors:  Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 7.792

Review 4.  Left ventricular non-compaction cardiomyopathy.

Authors:  Jeffrey A Towbin; Angela Lorts; John Lynn Jefferies
Journal:  Lancet       Date:  2015-04-09       Impact factor: 79.321

5.  T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.

Authors:  Rocio Hinojar; Niharika Varma; Nick Child; Benjamin Goodman; Andrew Jabbour; Chung-Yao Yu; Rolf Gebker; Adelina Doltra; Sebastian Kelle; Sitara Khan; Toby Rogers; Eduardo Arroyo Ucar; Ciara Cummins; Gerald Carr-White; Eike Nagel; Valentina O Puntmann
Journal:  Circ Cardiovasc Imaging       Date:  2015-12       Impact factor: 7.792

6.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

7.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

Authors:  Fabian aus dem Siepen; Sebastian J Buss; Daniel Messroghli; Florian Andre; Dirk Lossnitzer; Sebastian Seitz; Marius Keller; Philipp A Schnabel; Evangelos Giannitsis; Grigorios Korosoglou; Hugo A Katus; Henning Steen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-09-22       Impact factor: 6.875

8.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

9.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Andrew Jabbour; Tevfik F Ismail; Kaushik Guha; Jahanzaib Khwaja; Sadaf Raza; Kishen Morarji; Tristan D H Brown; Nizar A Ismail; Marc R Dweck; Elisa Di Pietro; Michael Roughton; Ricardo Wage; Yousef Daryani; Rory O'Hanlon; Mary N Sheppard; Francisco Alpendurada; Alexander R Lyon; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

10.  Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners.

Authors:  Fabio S Raman; Nadine Kawel-Boehm; Neville Gai; Melanie Freed; Jing Han; Chia-Ying Liu; Joao A C Lima; David A Bluemke; Songtao Liu
Journal:  J Cardiovasc Magn Reson       Date:  2013-07-26       Impact factor: 5.364
View more
  1 in total

1.  Cardiovascular magnetic resonance T2* mapping for structural alterations in hypertrophic cardiomyopathy.

Authors:  Mareike Gastl; Alexander Gotschy; Jochen von Spiczak; Malgorzata Polacin; Florian Bönner; Christiane Gruner; Malte Kelm; Frank Ruschitzka; Hatem Alkadhi; Sebastian Kozerke; Robert Manka
Journal:  Eur J Radiol Open       Date:  2019-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.